Hot Pursuit     09-Feb-21
AstraZeneca Pharma tumbles after Q3 PAT declines 21% YoY
AstraZeneca Pharma India lost 4.24% to Rs 3734.05 after the company's net profit declined 21.2% to Rs 21.05 crore in Q3 FY21 from Rs 26.7 crore in Q3 FY20.
Net sales for Q3 FY21 stood at Rs 200.25 crore, a 10.5% fall over Rs 223.86 crore recorded in Q3 FY20. The result was announced after market hours yesterday, 8 February 2021.

Profit before tax fell 19.6% to Rs 28.30 crore in Q3 FY21 over Q3 FY20. Tax expense fell 12.1% to Rs 7.74 crore in Q3 FY21 over Q3 FY20.

AstraZeneca Pharma India is engaged in the discovery, development and commercialization of medicines for core areas of healthcare, including cardiovascular/metabolic disease, cancer and respiratory, inflammatory and autoimmune disease.

Previous News
  Astrazeneca Pharma India standalone net profit declines 38.28% in the March 2023 quarter
 ( Results - Announcements 31-May-23   07:43 )
  Volumes jump at Astrazeneca Pharma India Ltd counter
 ( Hot Pursuit - 12-Sep-22   14:30 )
  AstraZeneca Pharma Q4 PAT soars 129% YoY to Rs 39 cr
 ( Hot Pursuit - 28-May-24   11:45 )
  Volumes soar at Astrazeneca Pharma India Ltd counter
 ( Hot Pursuit - 04-Jul-24   14:30 )
  Astrazeneca Pharma India schedules board meeting
 ( Corporate News - 04-Aug-20   10:39 )
  Astrazeneca Pharma India fixes record date for final dividend
 ( Market Beat - Reports 27-Jun-22   17:01 )
  Astrazeneca Pharma India Ltd leads gainers in 'A' group
 ( Hot Pursuit - 27-May-22   12:00 )
  Astrazeneca Pharma soars after receiving regulatory nod for importing Andexxa
 ( Hot Pursuit - 20-Jan-24   13:14 )
  Astrazeneca Pharma India receives DCGI approval to import, market Selumetinib capsules
 ( Hot Pursuit - 27-Sep-21   09:37 )
  Astrazeneca Pharma India to hold board meeting
 ( Corporate News - 19-May-21   09:45 )
  Board of AstraZeneca Pharma India approves change in directorate
 ( Corporate News - 03-Dec-16   09:21 )
Other Stories
  Dhanlaxmi Bank gains as gross advances rises 6% YoY in Q1 FY25
  05-Jul-24   15:27
  HDFC Bank Ltd leads losers in 'A' group
  05-Jul-24   15:00
  Shilpa Medicare sizzles after Unicycive gets positive results in clinical trials of OLC
  05-Jul-24   14:52
  Manugraph India Ltd leads losers in 'B' group
  05-Jul-24   14:45
  NSE SME Nephro Care India rallies on listing day
  05-Jul-24   14:45
  ESAF SFB total deposits jumps 33% YoY in Q1
  05-Jul-24   14:43
  Utkarsh SFB deposits climb 30% YoY in Q1 FY25
  05-Jul-24   14:35
  Volumes soar at Medplus Health Services Ltd counter
  05-Jul-24   14:30
  Financials stocks slide
  05-Jul-24   14:00
  Banking stocks edge lower
  05-Jul-24   14:00
Back Top